Analyst Ratings for Outlook Therapeutics Inc. (OTLK)
OTLK Rating Summary
OTLK Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$6.75 (+1546.3%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 64%
Avg. $ Target:
$6.75 (+1546.3%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 64%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/29/2025 | H.C. Wainwright » Updated 1/5/2026 |
Douglas Tsao | Downgrade | Neutral (Buy) |
0.50 (1.00) |
1.09 (0.41) |
-62.39% | Details |
| 8/28/2025 | Guggenheim | Eddie Hickman | Downgrade | Neutral (Buy) |
N/A (N/A) |
2.38 (0.41) |
-82.77% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
